Slow-Acting Antirheumatic Drugs Drug Interactions of Clinical Significance
Authors:
- 1 July 1995
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 13 (1) , 25-30
Abstract
The slow-acting antirheumatic drugs (SAARDs) are being used in an increasing proportion of patients with rheumatoid arthritis (RA). The potential toxicity of each drug is well recognised. Many patients with RA will be on other medications and the potential for adverse drug interactions with SAARDs is not so well publicised. There have, over the years, been numerous reports of possible drug interactions with SAARDs but few of these are clinically relevant. It is, however, vitally important that the physician is aware of a number of potentially life-threatening interactions, particularly those associated with methotrexate. The SAARDs are a very useful group of drugs for the treatment of RA and, by being aware of their potential toxicity and drug interactions, hopefully they can be used safely and effectively.Keywords
This publication has 29 references indexed in Scilit:
- Bladder cancer in patients on low-dose methotrexate and corticosteroidsThe Lancet, 1994
- Renal effects of aspirin and low dose methotrexate in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1993
- Nitritoid Reactions and Angiotensin-Converting-Enzyme InhibitorsNew England Journal of Medicine, 1989
- A three year follow up of patients allocated to placebo, or oral or injectable gold therapy for rheumatoid arthritis.Annals of the Rheumatic Diseases, 1986
- Megaloblastic pancytopenia in a patient receiving concurrent methotrexate and trimethoprim‐sulfamethoxazole treatmentArthritis & Rheumatism, 1986
- Influence of previous gold toxicity on subsequent development of penicillamine toxicity.BMJ, 1982
- Does the order of second-line treatment in rheumatoid arthritis matter?BMJ, 1982
- Adverse reactions to D-penicillamine after gold toxicity.BMJ, 1980
- The Effect of Penicillamine on Serum Digoxin LevelsJapanese Heart Journal, 1978
- Clinical Pharmacokinetics of Methotrexate1Clinical Pharmacokinetics, 1978